companydata.dkcompanydata.dk

MISSIONPHARMA A/S: Financial statements 2025

CVR: 26902398

Source: annual report 2025, Danish Business Authority

01/04/2024 – 31/03/2025

MISSIONPHARMA A/S (CVR 26902398) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 741,955,000 and a net result of DKK 73,402,000 compared with DKK 119,865,000 the year before. That is a decrease of 21.1% compared with the year before. The profit margin was 9.9%. Equity in the 2025 report amounted to DKK 273,135,000. The solvency ratio was 67.7%. The company had 169 employees in the financial year.

Revenue
DKK 741,955,000
Gross Profit
DKK 148,010,000
Profit/Loss
DKK 73,402,000
Equity
DKK 273,135,000
Total Assets
DKK 403,205,000
Employees
169

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025742M148M73.4M273.1M169
2024940.1M203.6M119.9M319.3M158
2023942.5M215.1M119.2M340.8M58
2022694M122.3M58M312.8M55
2021731.5M171.9M83.6M332.4M58

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MISSIONPHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About MISSIONPHARMA A/S

MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jean-Marc Pierre René Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre René Leccia. The company is owned by CFAO HEALTHCARE SA. The company has 60 employees (2026). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.

Source: annual report 2026, Danish Business Authority